SMSLIFE — SMS Lifesciences India Balance Sheet
0.000.00%
- IN₹4.23bn
- IN₹5.30bn
- IN₹3.06bn
- 73
- 30
- 82
- 69
Annual balance sheet for SMS Lifesciences India, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 21.6 | 106 | 32 | 36.1 | 5.7 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 287 | 459 | 576 | 603 | 652 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,072 | 1,263 | 1,560 | 1,591 | 1,553 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1,228 | 1,510 | 1,931 | 2,291 | 2,293 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 2,528 | 3,023 | 3,567 | 3,949 | 3,905 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 870 | 1,136 | 1,354 | 1,336 | 1,446 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 1,371 | 1,731 | 2,045 | 2,263 | 2,137 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 1,157 | 1,292 | 1,522 | 1,686 | 1,768 |
Total Liabilities & Shareholders' Equity | 2,528 | 3,023 | 3,567 | 3,949 | 3,905 |
Total Common Shares Outstanding |